Search Page
Filters
Search Results
4,759 results
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.
Cancer Res. 1995 Oct 15;55(20):4525-30.
Cancer Res. 1995.
PMID: 7553621
5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers.
Nat Med. 1995 Jul;1(7):686-92. doi: 10.1038/nm0795-686.
Nat Med. 1995.
PMID: 7585152
Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
Cancer Res. 1995 Dec 15;55(24):6200-9.
Cancer Res. 1995.
PMID: 8521414
Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions.
Cancer Res. 1997 Dec 1;57(23):5356-9.
Cancer Res. 1997.
PMID: 9393760
Cancer screening based on genetic alterations in human tumors.
Cancer Res. 1994 Apr 1;54(7 Suppl):1939s-1940s.
Cancer Res. 1994.
PMID: 8137315
Review.
No abstract available.
Frequency of homozygous deletion at p16/CDKN2 in primary human tumours.
Nat Genet. 1995 Oct;11(2):210-2. doi: 10.1038/ng1095-210.
Nat Genet. 1995.
PMID: 7550353
Tetranucleotide repeat polymorphism in RAF1.
Hum Mol Genet. 1994 Mar;3(3):521. doi: 10.1093/hmg/3.3.521-a.
Hum Mol Genet. 1994.
PMID: 8012371
No abstract available.
Detection of oncogene mutations in sputum precedes diagnosis of lung cancer.
Cancer Res. 1994 Apr 1;54(7):1634-7.
Cancer Res. 1994.
PMID: 8137272
Clinical Trial.
Molecular detection of primary bladder cancer by microsatellite analysis.
Science. 1996 Feb 2;271(5249):659-62. doi: 10.1126/science.271.5249.659.
Science. 1996.
PMID: 8571131
Cite